Background: Brucellosis is a zoonotic endemic disease, the main source of infection is infected cattle, sheep, pigs and their products. In recent years, the global incidence of brucellosis spondylitis has increased year by year, and it has spread from pastoral areas to semi-agricultural and semi-pastoral areas, agricultural areas and cities. It has changed from a mainly occupational disease to a mainly food-borne disease, and it is also a zoonotic specific spinal infectious disease that WHO and governments around the world pay great attention to. Due to the low cure rate and high recurrence rate of traditional drug therapy regimen. Therefore, to carry out epidemiological investigation and Related research on clinical drug therapy of brucellosis spondylitis has practical significance for improving diagnosis rate, cure rate and reducing recurrence rate. Objective: To analyze the epidemiological characteristics of Brucellosis spondylitis and explore the choice of drugs and the best drug treatment plan, so as to provide scientific basis for improving the prevention and control of the disease and treatment effect. Methods: Clinical epidemiodogical materials were collected from 113 patients with brucellar spondylitis. All these patients were divided into 5 different groups according to 5 kinds of drugs adopted respectively, and then the patients were given different course of treatment. Results: In the 113 patients, brucellar spondylitis morbility of female patients were higher than that of male ones, and the morbility of Bashang were higher than that of Baxia. These patients were infected mainly through browsing and breeding beasts. Lumbars were the major focus of infection. It was very comnlon that two adjacent lumbars were involved in concurrently. L4 was the most common infection location and its demolishment was most serious. The curative effect of group treated with doxycycline was better than that of group treated without doxycycline. If the course of treatment Was increased, the curative effect Was not increased obviously. Conclusions: There are characteristic features in clinical epidemiology of brucell spondylitis. Doxycycline + Rifampicin + Sulfamethoxazole was used as the preferred antibiotic. Using antibiotics adequately and jointly by two courses of treatment for a long time is the most reasonable way to treat the disease and prevent the disease from recurrence.
References
[1]
Yang, X.M., Zhang, X.Y., Yang, C.W. and Zhang, Z. (2023) Establishment of Clinical Diagnostic System and Imaging Classification Standard for Brucello Spondylitis and Its Clinical Significance. Chinese Journal of Bone and Joint Surgery, 16, 120-130.
[2]
Yang, X.M., Yang, C.W., Yao, Y., Tian, Y., Chen, L.X. and Zhang, Y. (2022) Clinical Study on Standardized Diagnosis of Brucellosis Spondylitis. Chinese Journal of Diagnostics, 10, 217-223.
[3]
Yang, X.M., Zhang, Y., Shi, W., Yao, Y. and Tian, Y. (2020) Establishment of Clinical Diagnosis System and Evaluation of Curative Effect of Brucellosis Spondylitis in the Elderly. Chinese Journal of Geriatric Orthopaedics and Rehabilitation Medicine, 6, 39-47.
[4]
Shi, Y.J., Lai, S.J. and Chen, Q. (2017) Analysis on the Epidemiological Features of Human Brucellosis in Northern and Southern Areas of China, 2015-2016. Chinese Journal of Epidemiology, 38, 435-440.
[5]
Yin, Y.L., Yang, X.M., Tian, Y., Zhang, Y. and Zhang, P.N. (2017) Clinical Epidemiological Characteristics, Diagnosis and Treatment of Patient with Brucellosis Spondylitis. Chinese Journal of Nosocomiology, 29, 2820-2824.
[6]
Zhang, Z., Yang, X.M., Shi, W., Jia, Y.L. and Zhang, P. (2017) Diagnosis and Treatment of Lumbar Brucellosis Spondylitis. Chinese Journal of Experimental and Clinical Infectious Diseases, 8, 8-13.
[7]
Yang, X.M., Jia, Y.L., Zhang, Y., Zhang, P.N., Yao, Y., Yin, Y.L. and Tian, Y. (2021) Clinical Effect of Doxycycline Combined with Compound Sulfamethoxazole and Rifampicin in the Treatment of Brucellosis Spondylitis. Drug Design, Development and Therapy, 15, 4733-4740. https://doi.org/10.2147/DDDT.S341242
[8]
Solera, J., Geijo, P., Largo, J., et al. (2004) Arandomized, Double-Blind Study to Assess the Optimal Duration of Doxyeycline Treatment for Human Brucellosis. Clinical Infectious Diseases, 39, 1776-1782. https://doi.org/10.1086/426024
[9]
Chen, L.X., Yang, X.M. and Zhang, Y. (2020) Research Progress in Diagnosis and Treatment of Brucellar Spondylitis. Journal of Hebei North University, 36, 57-61.
[10]
Yang, X.M., Shi, W., Meng, X.Y., Zhang, Y., Du, Y.K., Zhang, L. and Wang, Y.Y. (2013) The Assessment of the Clinical Effect of the Drug Compatibility and Course of Treatment to the Brucellar Spondyliti. Surgical Science, 4, 92-99. https://doi.org/10.4236/ss.2013.41017
[11]
Yang, X.M., Jia, Y.L., Zhang, Y., Yin, Y.L., Zhang, P.N., Tian, Y., Yao, Y. and Chen, L.X. (2022) Establishment and Clinical Application of One-Stage Posterior Limited Lesion Clearance and Internal Fixation Combined with Personalized Drug Therapy System for Brucellosis Spondylitis. Chinese Journal of Anatomy and Clinical Anatomy, 27, 98-105. https://doi.org/10.21203/rs.3.rs-146670/v1
